Rationale Use of Thromboprophylaxis to Prevent Venous Thromboembolism (VTE) in Women Ongoing Assisted Reproductive Technologies
Pierpaolo Di Micco, Vincenzo Russo,
Pasquale De Rosa, Luisa Avino, Rita
Amoroso, Vincenzo Marrone, Ida Strina
Correspondence Address :
Pierpaolo Di Micco
Fatebenefratelli Hospital of Naples
Received on: March 23, 2018, Accepted on: April 10, 2018, Published on: April 16, 2018
Citation: Pierpaolo Di Micco, Vincenzo Russo, Pasquale De Rosa, et al. (2018) Treatment of Endothelial Permeability with Hemostatic Factors
Copyright: 2018 Pierpaolo Di Micco, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Assisted Reproductive Technologies (ART) procedures because haemostatic changes due to hormonal treatment and biological prothrombotic changes during ovarian hyperstimulation and following pregnancy may be associated to increases risk of VTE. In recent years several articles discussed the needful support of LMWH not only to reduce VTE incidence in this clinical setting but also to increase the rate of successful pregnancy after ART. There are not guidelines to suggest antithrombotic treatment in both cases nor in regular patients nor in thrombophilic patients. Yet during ART procedures may be present additional prothrombotic condition that may suggest us to evaluate to add antithrombotic treatment to prevent VTE.